Press release
Global Nanomedicine Market & Pipeline Insight 2015
Nanomedicines or nanotherapeutics is an emerging field in which nanotechnology principles are used to design and develop better therapeutics having high safety and efficacy profiles. It is a multidisciplinary approach utilizing knowledge from allied fields like biotechnology and pharmacology in drug development program. Novel modalities for cancer treatment, targeted drug delivery, biosensors, imaging, delivery vehicles and diagnostic methods are being actively investigated by pharmaceutical companies. They have been widely accepted among physicians and patients due to which novel products are expected to generate significant revenues. Several other benefits have yet to be discovered which will further help in the extension of this field. With time, more technological advancements are expected to be made resulting in development better of nanomedicines for several disease indications.Pharmaceutical companies are developing better drug delivery vehicles with the help of nanotechnology. Unspecificity causes undue wastage of drug, potency reduction and undue side effects during therapy. This problem become serious when patient is suffering from life threatening disease like cancer and use of chemotherapy is a part of therapeutic regime. Easy modification, customizability and cost of product are expected to be the main reasons determining the commercial success besides their pharmacological benefits. Huge investments in research and development are expected to help in identifying useful nanoparticles based drug delivery vehicles. Several methods have been identified by pharmaceutical companies in past few years and many more are being under development.
Download Report:
https://www.kuickresearch.com/report-Global-Nanomedicine-Market-&-Pipeline-Insight-2015.php
Use of nanomedicines for cancer is one of the largest and most developed segments containing several products in both market and clinical pipeline. Nanotechnology based liposome products could be observed as one of the most advance segment among oncology medicines. For instance, Doxil by Ortho pharmaceuticals was among first approved cancer nanomedicines by US FDA in 1995 for treating AIDS-related Kaposi’s sarcoma. DaunoXome by Galen Ltd is also a liposomal formulation used for the treatment of HIV relates Kaposi sarcoma and clinical trials for utilization of this medicine for leukemia is also under investigation. More products are at different stages of clinical trials which will be introduced in global market in coming years.
Numerous nanotechnology based medicines, devices, sensors and chips are at various phases of clinical development. Only limited products are in market for few indications which is mainly responsible for small market size as compared to mainstream medicines. Their clinical pipeline is becoming strong every year and new initiatives are being taken by pharmaceutical companies but as such number of market introductions is less. Without immediate commercialization of such products their market size will be limited which will cause stagnancy. In order to overcome these barriers, pace of research and development along with market introduction has to be increased in coming time. It would help in generating significant revenues but it will take few years for nanomedicines to get recognition as mainstream medicines. But, the pace at which they are growing shows optimistic future of nanomedicines and associated medical technologies.
“Global Nanomedicine Market & Pipeline Insight 2015” Report Highlights:
* Global Nanomedicine Market Outlook
* Global Nanomedicine Market Dynamics
* Global Nanomedicine Clinical Pipeline by Company, Indication & Phase
* Global Nanomedicine Clinical Pipeline: 144 Nanomedicines
* Marketed Nanomedicines: 13 Nanomedicines
* Nanomedicine Patent Analysis
* Global Nanomedicine Market Future Prospects
For Report Sample Contact: neeraj@kuickresearch.com or
visit: https://www.kuickresearch.com
Recent Publications:
* Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022
* Global CAR T Cell Therapy Market & Clinical Trials Insight 2022
* Global Dendritic Cell Cancer Vaccine Market & Clinical Trials Outlook 2023
* Global Microcapsules Drug Delivery Market Opportunity Outlook 2022
* Global Controlled Drug Delivery Market & Clinical Trial Outlook 2022
* Global Cancer Antibody Drug Conjugates Market & Pipeline Insight 2022
* Global B Cell Lymphoma Market & Clinical Pipeline Insight 2022
Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.
Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India
+91-11-47067990
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Nanomedicine Market & Pipeline Insight 2015 here
News-ID: 601143 • Views: …
More Releases from Kuick Resarch

Targeted Alpha Therapy Market
Global Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight 2028 Report Highlights:
• Global Targeted Alpha Therapy Market Insight By Region
• Approved Targeted Alpha Therapy Dosage & Pricing Insight
• Number Of Targeted Alpha Therapy In Clinical Trials: > 20 Drugs
• Targeted Alpha Therapy Clinical Trials Insight By Company, Country, Indication & Phase
• Marketed Targeted Alpha Therapy Clinical Insight By Company, Country & Indication
• Targeted Alpha Therapy Proprietary Technology Platform Insights By…

Global Cancer Antibody Drug Conjugates Market
Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030 Report Finding & Inclusions:
• Global Cancer Antibody Drug Conjugates Market: 2020 - 2030
• Global Cancer Antibody Drug Conjugates Market Opportunity > US$ 50 Billion By 2030
• Approved Cancer Antibody Drug Conjugates: 16 Drugs
• Approved Cancer Antibody Drug Conjugates Sales Insights, Patent, Dosage and Price Analysis
• Cancer Antibody Drug Conjugates In Clinical Trials: > 500 Drugs
• Cancer Antibody Drug Conjugates Clinical…

Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…

Bispecific Antibody Drug Conjugates Development
The development of bispecific antibody drug conjugates (ADCs) marks a significant advancement in the field of targeted cancer therapy. These innovative molecules combine the specificity of bispecific antibodies with the powerful cytotoxic effects of drug conjugates, creating a new class of therapeutic agents that hold great promise for treating complex and resistant cancers. The process of developing these ADCs involves intricate design, engineering, and testing to ensure their safety, efficacy,…
More Releases for Nanomedicine
Nanomedicine Market - Next Breakthrough in Oncology & A Realistic look at the Pr …
Nanomedicine is an application of nanotechnology in the field of diagnosing, treating and preventing disease and traumatic injury, of relieving pain, and improving human health with the application of molecular knowledge and tools. It is a combination of five sub-disciplines Nanomaterials, Novel Therapeutics and Drug Delivery Systems, Nanodevices, Analytical Tools Nanoimaging and Clinical, Regulatory and Toxicological Issues.
Nanomedicine aims at comprehensive monitoring, repair, control, defense, construction and improvement of all human…
Global Cancer Nanomedicine Market Outlook 2022 Report
“Global Cancer Nanomedicine Market Outlook 2022” Report Highlights:
* Overview and Mechanism of Action of Nanomedicine
* Nanomedicine Engineering: Design and Strategy
* Cancer Nanomedicine as Diagnostic and Therapeutics Tool
* Global Cancer Nanomedicine Market Overview and Dynamics
* Global Cancer Nanomedicine Clinical Pipeline by Company, Indication and Phase
* Global Cancer Nanomedicine Clinical Pipeline: 124 Drug
* Marketed Cancer Nanomedicine: 8 Drugs
Download Report Sample Weblink:
https://www.kuickresearch.com/report-global-cancer-nanomedicine-market-outlook-2022.php
For Report Sample Contact: neeraj@kuickresearch.com
Table of Contents
Cancer Nanomedicine:…
Cancer Nanomedicine Market Cancer Nanomedicine Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Cancer Nanomedicine: An Optimistic Avenue
1.1 Introduction
1.2 Emergence of Nanomedicines
Prerequisite of Nanomedicines
2.1 Conventional Cancer Treating Approaches
2.2 Nanomedicines: Overcoming the Hurdles
Diversification of Nanomedicines
3.1 Classification on Basis of Constituents
3.1.1 Inorganic Nanoparticles
3.1.2 Organic Nanoparticles
3.2 Classification on Basis of Applicability
3.2.1…
Global Cancer Nanomedicine Market & Cancer Nanomedicine Clinical Trials Outlook …
Over the past several years, many innovative and revolutionary techniques have been developed in order to treat cancer. These techniques range from basic surgical removal to X-ray irradiation to system wide flooding with anticancer agents. However, each of these approaches has its own series of undesirable side effects that are both dangerous and damaging to the overall health of the patient. On the contrary, very recent breakthroughs in nanomedicine have…
Global Cancer Nanomedicine Market Outlook 2022
Over the past several years, many innovative and revolutionary techniques have been developed in order to treat cancer. These techniques range from basic surgical removal to X-ray irradiation to system wide flooding with anticancer agents. However, each of these approaches has its own series of undesirable side effects that are both dangerous and damaging to the overall health of the patient. On the contrary, recent breakthroughs in nanomedicine have managed…
Global Cancer Nanomedicine Market Outlook 2022
Over the past several years, many innovative and revolutionary techniques have been developed in order to treat cancer. These techniques range from basic surgical removal to X-ray irradiation to system wide flooding with anticancer agents. However, each of these approaches has its own series of undesirable side effects that are both dangerous and damaging to the overall health of the patient. On the contrary, recent breakthroughs in nanomedicine have managed…